Viral Vectors & Plasmid DNA Manufacturing Market

ID: MRFR/HC/9195-HCR
200 Pages
Rahul Gotadki
Last Updated: May 15, 2026
Viral Vectors and Plasmid DNA Manufacturing Market Research Report: Size, Share, Trend Analysis By Applications (Gene Therapy, Vaccine Development, Transgenic Research, Cell and Gene Editing), By Types (Viral Vectors, Plasmid DNA, RNA-based Vectors), By Technology (Viral Transduction, Electroporation, Microinjection, Liposomal Delivery), By End Use (Pharmaceutical Companies, Biotechnology Firms, Research Institutions) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035
Viral Vectors & Plasmid DNA Manufacturing Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)13.26%
2024 Market Size$ 0.4 Billion
2025 Market Size$ 0.45 Billion
2035 Market Size$ 1.57 Billion
Key Players
Companies such as Lonza
Boehringer Ingelheim
Sartorius
Thermo Fisher Scientific
WuXi AppTec
Cobra Biologics
Trends
  • Rising Demand for Gene Therapies
  • Technological Advancements in Production
  • Collaborative Research Initiatives
Opportunities
  • Rising Investment in Biotechnology
  • Growing Demand for Personalized Medicine
  • Increasing Prevalence of Genetic Disorders
Summary Table of Contents Segmentation Methodology Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Healthcare, BY Application (USD Billion)
      1. 4.1.1 Gene Therapy
      2. 4.1.2 Vaccines
      3. 4.1.3 Oncology
      4. 4.1.4 Infectious Diseases
      5. 4.1.5 Genetic Disorders
    2. 4.2 Healthcare, BY End Use (USD Billion)
      1. 4.2.1 Pharmaceutical Companies
      2. 4.2.2 Biotechnology Firms
      3. 4.2.3 Research Institutions
      4. 4.2.4 Academic Organizations
    3. 4.3 Healthcare, BY Type of Viral Vector (USD Billion)
      1. 4.3.1 Adenoviral Vectors
      2. 4.3.2 Lentiviral Vectors
      3. 4.3.3 Adeno-Associated Viral Vectors
      4. 4.3.4 Retroviral Vectors
    4. 4.4 Healthcare, BY Scale of Production (USD Billion)
      1. 4.4.1 Small Scale
      2. 4.4.2 Medium Scale
      3. 4.4.3 Large Scale
    5. 4.5 Healthcare, BY Technology Used (USD Billion)
      1. 4.5.1 Transfection
      2. 4.5.2 Electroporation
      3. 4.5.3 Viral Packaging
      4. 4.5.4 Microinjection
    6. 4.6 Healthcare, BY Region (USD Billion)
      1. 4.6.1 North America
        1. 4.6.1.1 US
        2. 4.6.1.2 Canada
      2. 4.6.2 Europe
        1. 4.6.2.1 Germany
        2. 4.6.2.2 UK
        3. 4.6.2.3 France
        4. 4.6.2.4 Russia
        5. 4.6.2.5 Italy
        6. 4.6.2.6 Spain
        7. 4.6.2.7 Rest of Europe
      3. 4.6.3 APAC
        1. 4.6.3.1 China
        2. 4.6.3.2 India
        3. 4.6.3.3 Japan
        4. 4.6.3.4 South Korea
        5. 4.6.3.5 Malaysia
        6. 4.6.3.6 Thailand
        7. 4.6.3.7 Indonesia
        8. 4.6.3.8 Rest of APAC
      4. 4.6.4 South America
        1. 4.6.4.1 Brazil
        2. 4.6.4.2 Mexico
        3. 4.6.4.3 Argentina
        4. 4.6.4.4 Rest of South America
      5. 4.6.5 MEA
        1. 4.6.5.1 GCC Countries
        2. 4.6.5.2 South Africa
        3. 4.6.5.3 Rest of MEA
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Healthcare
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Lonza (CH)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Sartorius (DE)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Thermo Fisher Scientific (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Merck KGaA (DE)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Boehringer Ingelheim (DE)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Cobra Biologics (GB)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Viva Biotech (CN)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 GenScript (CN)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 Wuxi AppTec (CN)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
      10. 5.2.10 Aldevron (US)
        1. 5.2.10.1 Financial Overview
        2. 5.2.10.2 Products Offered
        3. 5.2.10.3 Key Developments
        4. 5.2.10.4 SWOT Analysis
        5. 5.2.10.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 NORTH AMERICA MARKET ANALYSIS
    3. 6.3 US MARKET ANALYSIS BY APPLICATION
    4. 6.4 US MARKET ANALYSIS BY END USE
    5. 6.5 US MARKET ANALYSIS BY TYPE OF VIRAL VECTOR
    6. 6.6 US MARKET ANALYSIS BY SCALE OF PRODUCTION
    7. 6.7 US MARKET ANALYSIS BY TECHNOLOGY USED
    8. 6.8 CANADA MARKET ANALYSIS BY APPLICATION
    9. 6.9 CANADA MARKET ANALYSIS BY END USE
    10. 6.10 CANADA MARKET ANALYSIS BY TYPE OF VIRAL VECTOR
    11. 6.11 CANADA MARKET ANALYSIS BY SCALE OF PRODUCTION
    12. 6.12 CANADA MARKET ANALYSIS BY TECHNOLOGY USED
    13. 6.13 EUROPE MARKET ANALYSIS
    14. 6.14 GERMANY MARKET ANALYSIS BY APPLICATION
    15. 6.15 GERMANY MARKET ANALYSIS BY END USE
    16. 6.16 GERMANY MARKET ANALYSIS BY TYPE OF VIRAL VECTOR
    17. 6.17 GERMANY MARKET ANALYSIS BY SCALE OF PRODUCTION
    18. 6.18 GERMANY MARKET ANALYSIS BY TECHNOLOGY USED
    19. 6.19 UK MARKET ANALYSIS BY APPLICATION
    20. 6.20 UK MARKET ANALYSIS BY END USE
    21. 6.21 UK MARKET ANALYSIS BY TYPE OF VIRAL VECTOR
    22. 6.22 UK MARKET ANALYSIS BY SCALE OF PRODUCTION
    23. 6.23 UK MARKET ANALYSIS BY TECHNOLOGY USED
    24. 6.24 FRANCE MARKET ANALYSIS BY APPLICATION
    25. 6.25 FRANCE MARKET ANALYSIS BY END USE
    26. 6.26 FRANCE MARKET ANALYSIS BY TYPE OF VIRAL VECTOR
    27. 6.27 FRANCE MARKET ANALYSIS BY SCALE OF PRODUCTION
    28. 6.28 FRANCE MARKET ANALYSIS BY TECHNOLOGY USED
    29. 6.29 RUSSIA MARKET ANALYSIS BY APPLICATION
    30. 6.30 RUSSIA MARKET ANALYSIS BY END USE
    31. 6.31 RUSSIA MARKET ANALYSIS BY TYPE OF VIRAL VECTOR
    32. 6.32 RUSSIA MARKET ANALYSIS BY SCALE OF PRODUCTION
    33. 6.33 RUSSIA MARKET ANALYSIS BY TECHNOLOGY USED
    34. 6.34 ITALY MARKET ANALYSIS BY APPLICATION
    35. 6.35 ITALY MARKET ANALYSIS BY END USE
    36. 6.36 ITALY MARKET ANALYSIS BY TYPE OF VIRAL VECTOR
    37. 6.37 ITALY MARKET ANALYSIS BY SCALE OF PRODUCTION
    38. 6.38 ITALY MARKET ANALYSIS BY TECHNOLOGY USED
    39. 6.39 SPAIN MARKET ANALYSIS BY APPLICATION
    40. 6.40 SPAIN MARKET ANALYSIS BY END USE
    41. 6.41 SPAIN MARKET ANALYSIS BY TYPE OF VIRAL VECTOR
    42. 6.42 SPAIN MARKET ANALYSIS BY SCALE OF PRODUCTION
    43. 6.43 SPAIN MARKET ANALYSIS BY TECHNOLOGY USED
    44. 6.44 REST OF EUROPE MARKET ANALYSIS BY APPLICATION
    45. 6.45 REST OF EUROPE MARKET ANALYSIS BY END USE
    46. 6.46 REST OF EUROPE MARKET ANALYSIS BY TYPE OF VIRAL VECTOR
    47. 6.47 REST OF EUROPE MARKET ANALYSIS BY SCALE OF PRODUCTION
    48. 6.48 REST OF EUROPE MARKET ANALYSIS BY TECHNOLOGY USED
    49. 6.49 APAC MARKET ANALYSIS
    50. 6.50 CHINA MARKET ANALYSIS BY APPLICATION
    51. 6.51 CHINA MARKET ANALYSIS BY END USE
    52. 6.52 CHINA MARKET ANALYSIS BY TYPE OF VIRAL VECTOR
    53. 6.53 CHINA MARKET ANALYSIS BY SCALE OF PRODUCTION
    54. 6.54 CHINA MARKET ANALYSIS BY TECHNOLOGY USED
    55. 6.55 INDIA MARKET ANALYSIS BY APPLICATION
    56. 6.56 INDIA MARKET ANALYSIS BY END USE
    57. 6.57 INDIA MARKET ANALYSIS BY TYPE OF VIRAL VECTOR
    58. 6.58 INDIA MARKET ANALYSIS BY SCALE OF PRODUCTION
    59. 6.59 INDIA MARKET ANALYSIS BY TECHNOLOGY USED
    60. 6.60 JAPAN MARKET ANALYSIS BY APPLICATION
    61. 6.61 JAPAN MARKET ANALYSIS BY END USE
    62. 6.62 JAPAN MARKET ANALYSIS BY TYPE OF VIRAL VECTOR
    63. 6.63 JAPAN MARKET ANALYSIS BY SCALE OF PRODUCTION
    64. 6.64 JAPAN MARKET ANALYSIS BY TECHNOLOGY USED
    65. 6.65 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
    66. 6.66 SOUTH KOREA MARKET ANALYSIS BY END USE
    67. 6.67 SOUTH KOREA MARKET ANALYSIS BY TYPE OF VIRAL VECTOR
    68. 6.68 SOUTH KOREA MARKET ANALYSIS BY SCALE OF PRODUCTION
    69. 6.69 SOUTH KOREA MARKET ANALYSIS BY TECHNOLOGY USED
    70. 6.70 MALAYSIA MARKET ANALYSIS BY APPLICATION
    71. 6.71 MALAYSIA MARKET ANALYSIS BY END USE
    72. 6.72 MALAYSIA MARKET ANALYSIS BY TYPE OF VIRAL VECTOR
    73. 6.73 MALAYSIA MARKET ANALYSIS BY SCALE OF PRODUCTION
    74. 6.74 MALAYSIA MARKET ANALYSIS BY TECHNOLOGY USED
    75. 6.75 THAILAND MARKET ANALYSIS BY APPLICATION
    76. 6.76 THAILAND MARKET ANALYSIS BY END USE
    77. 6.77 THAILAND MARKET ANALYSIS BY TYPE OF VIRAL VECTOR
    78. 6.78 THAILAND MARKET ANALYSIS BY SCALE OF PRODUCTION
    79. 6.79 THAILAND MARKET ANALYSIS BY TECHNOLOGY USED
    80. 6.80 INDONESIA MARKET ANALYSIS BY APPLICATION
    81. 6.81 INDONESIA MARKET ANALYSIS BY END USE
    82. 6.82 INDONESIA MARKET ANALYSIS BY TYPE OF VIRAL VECTOR
    83. 6.83 INDONESIA MARKET ANALYSIS BY SCALE OF PRODUCTION
    84. 6.84 INDONESIA MARKET ANALYSIS BY TECHNOLOGY USED
    85. 6.85 REST OF APAC MARKET ANALYSIS BY APPLICATION
    86. 6.86 REST OF APAC MARKET ANALYSIS BY END USE
    87. 6.87 REST OF APAC MARKET ANALYSIS BY TYPE OF VIRAL VECTOR
    88. 6.88 REST OF APAC MARKET ANALYSIS BY SCALE OF PRODUCTION
    89. 6.89 REST OF APAC MARKET ANALYSIS BY TECHNOLOGY USED
    90. 6.90 SOUTH AMERICA MARKET ANALYSIS
    91. 6.91 BRAZIL MARKET ANALYSIS BY APPLICATION
    92. 6.92 BRAZIL MARKET ANALYSIS BY END USE
    93. 6.93 BRAZIL MARKET ANALYSIS BY TYPE OF VIRAL VECTOR
    94. 6.94 BRAZIL MARKET ANALYSIS BY SCALE OF PRODUCTION
    95. 6.95 BRAZIL MARKET ANALYSIS BY TECHNOLOGY USED
    96. 6.96 MEXICO MARKET ANALYSIS BY APPLICATION
    97. 6.97 MEXICO MARKET ANALYSIS BY END USE
    98. 6.98 MEXICO MARKET ANALYSIS BY TYPE OF VIRAL VECTOR
    99. 6.99 MEXICO MARKET ANALYSIS BY SCALE OF PRODUCTION
    100. 6.100 MEXICO MARKET ANALYSIS BY TECHNOLOGY USED
    101. 6.101 ARGENTINA MARKET ANALYSIS BY APPLICATION
    102. 6.102 ARGENTINA MARKET ANALYSIS BY END USE
    103. 6.103 ARGENTINA MARKET ANALYSIS BY TYPE OF VIRAL VECTOR
    104. 6.104 ARGENTINA MARKET ANALYSIS BY SCALE OF PRODUCTION
    105. 6.105 ARGENTINA MARKET ANALYSIS BY TECHNOLOGY USED
    106. 6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
    107. 6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USE
    108. 6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY TYPE OF VIRAL VECTOR
    109. 6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY SCALE OF PRODUCTION
    110. 6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY TECHNOLOGY USED
    111. 6.111 MEA MARKET ANALYSIS
    112. 6.112 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
    113. 6.113 GCC COUNTRIES MARKET ANALYSIS BY END USE
    114. 6.114 GCC COUNTRIES MARKET ANALYSIS BY TYPE OF VIRAL VECTOR
    115. 6.115 GCC COUNTRIES MARKET ANALYSIS BY SCALE OF PRODUCTION
    116. 6.116 GCC COUNTRIES MARKET ANALYSIS BY TECHNOLOGY USED
    117. 6.117 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
    118. 6.118 SOUTH AFRICA MARKET ANALYSIS BY END USE
    119. 6.119 SOUTH AFRICA MARKET ANALYSIS BY TYPE OF VIRAL VECTOR
    120. 6.120 SOUTH AFRICA MARKET ANALYSIS BY SCALE OF PRODUCTION
    121. 6.121 SOUTH AFRICA MARKET ANALYSIS BY TECHNOLOGY USED
    122. 6.122 REST OF MEA MARKET ANALYSIS BY APPLICATION
    123. 6.123 REST OF MEA MARKET ANALYSIS BY END USE
    124. 6.124 REST OF MEA MARKET ANALYSIS BY TYPE OF VIRAL VECTOR
    125. 6.125 REST OF MEA MARKET ANALYSIS BY SCALE OF PRODUCTION
    126. 6.126 REST OF MEA MARKET ANALYSIS BY TECHNOLOGY USED
    127. 6.127 KEY BUYING CRITERIA OF HEALTHCARE
    128. 6.128 RESEARCH PROCESS OF MRFR
    129. 6.129 DRO ANALYSIS OF HEALTHCARE
    130. 6.130 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    131. 6.131 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    132. 6.132 SUPPLY / VALUE CHAIN: HEALTHCARE
    133. 6.133 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
    134. 6.134 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
    135. 6.135 HEALTHCARE, BY END USE, 2024 (% SHARE)
    136. 6.136 HEALTHCARE, BY END USE, 2024 TO 2035 (USD Billion)
    137. 6.137 HEALTHCARE, BY TYPE OF VIRAL VECTOR, 2024 (% SHARE)
    138. 6.138 HEALTHCARE, BY TYPE OF VIRAL VECTOR, 2024 TO 2035 (USD Billion)
    139. 6.139 HEALTHCARE, BY SCALE OF PRODUCTION, 2024 (% SHARE)
    140. 6.140 HEALTHCARE, BY SCALE OF PRODUCTION, 2024 TO 2035 (USD Billion)
    141. 6.141 HEALTHCARE, BY TECHNOLOGY USED, 2024 (% SHARE)
    142. 6.142 HEALTHCARE, BY TECHNOLOGY USED, 2024 TO 2035 (USD Billion)
    143. 6.143 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY APPLICATION, 2025-2035 (USD Billion)
      2. 7.2.2 BY END USE, 2025-2035 (USD Billion)
      3. 7.2.3 BY TYPE OF VIRAL VECTOR, 2025-2035 (USD Billion)
      4. 7.2.4 BY SCALE OF PRODUCTION, 2025-2035 (USD Billion)
      5. 7.2.5 BY TECHNOLOGY USED, 2025-2035 (USD Billion)
    2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.3.1 BY APPLICATION, 2025-2035 (USD Billion)
      2. 7.3.2 BY END USE, 2025-2035 (USD Billion)
      3. 7.3.3 BY TYPE OF VIRAL VECTOR, 2025-2035 (USD Billion)
      4. 7.3.4 BY SCALE OF PRODUCTION, 2025-2035 (USD Billion)
      5. 7.3.5 BY TECHNOLOGY USED, 2025-2035 (USD Billion)
    3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
      1. 7.4.1 BY APPLICATION, 2025-2035 (USD Billion)
      2. 7.4.2 BY END USE, 2025-2035 (USD Billion)
      3. 7.4.3 BY TYPE OF VIRAL VECTOR, 2025-2035 (USD Billion)
      4. 7.4.4 BY SCALE OF PRODUCTION, 2025-2035 (USD Billion)
      5. 7.4.5 BY TECHNOLOGY USED, 2025-2035 (USD Billion)
    4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
      1. 7.5.1 BY APPLICATION, 2025-2035 (USD Billion)
      2. 7.5.2 BY END USE, 2025-2035 (USD Billion)
      3. 7.5.3 BY TYPE OF VIRAL VECTOR, 2025-2035 (USD Billion)
      4. 7.5.4 BY SCALE OF PRODUCTION, 2025-2035 (USD Billion)
      5. 7.5.5 BY TECHNOLOGY USED, 2025-2035 (USD Billion)
    5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
      1. 7.6.1 BY APPLICATION, 2025-2035 (USD Billion)
      2. 7.6.2 BY END USE, 2025-2035 (USD Billion)
      3. 7.6.3 BY TYPE OF VIRAL VECTOR, 2025-2035 (USD Billion)
      4. 7.6.4 BY SCALE OF PRODUCTION, 2025-2035 (USD Billion)
      5. 7.6.5 BY TECHNOLOGY USED, 2025-2035 (USD Billion)
    6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
      1. 7.7.1 BY APPLICATION, 2025-2035 (USD Billion)
      2. 7.7.2 BY END USE, 2025-2035 (USD Billion)
      3. 7.7.3 BY TYPE OF VIRAL VECTOR, 2025-2035 (USD Billion)
      4. 7.7.4 BY SCALE OF PRODUCTION, 2025-2035 (USD Billion)
      5. 7.7.5 BY TECHNOLOGY USED, 2025-2035 (USD Billion)
    7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
      1. 7.8.1 BY APPLICATION, 2025-2035 (USD Billion)
      2. 7.8.2 BY END USE, 2025-2035 (USD Billion)
      3. 7.8.3 BY TYPE OF VIRAL VECTOR, 2025-2035 (USD Billion)
      4. 7.8.4 BY SCALE OF PRODUCTION, 2025-2035 (USD Billion)
      5. 7.8.5 BY TECHNOLOGY USED, 2025-2035 (USD Billion)
    8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
      1. 7.9.1 BY APPLICATION, 2025-2035 (USD Billion)
      2. 7.9.2 BY END USE, 2025-2035 (USD Billion)
      3. 7.9.3 BY TYPE OF VIRAL VECTOR, 2025-2035 (USD Billion)
      4. 7.9.4 BY SCALE OF PRODUCTION, 2025-2035 (USD Billion)
      5. 7.9.5 BY TECHNOLOGY USED, 2025-2035 (USD Billion)
    9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
      1. 7.10.1 BY APPLICATION, 2025-2035 (USD Billion)
      2. 7.10.2 BY END USE, 2025-2035 (USD Billion)
      3. 7.10.3 BY TYPE OF VIRAL VECTOR, 2025-2035 (USD Billion)
      4. 7.10.4 BY SCALE OF PRODUCTION, 2025-2035 (USD Billion)
      5. 7.10.5 BY TECHNOLOGY USED, 2025-2035 (USD Billion)
    10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
      1. 7.11.1 BY APPLICATION, 2025-2035 (USD Billion)
      2. 7.11.2 BY END USE, 2025-2035 (USD Billion)
      3. 7.11.3 BY TYPE OF VIRAL VECTOR, 2025-2035 (USD Billion)
      4. 7.11.4 BY SCALE OF PRODUCTION, 2025-2035 (USD Billion)
      5. 7.11.5 BY TECHNOLOGY USED, 2025-2035 (USD Billion)
    11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
      1. 7.12.1 BY APPLICATION, 2025-2035 (USD Billion)
      2. 7.12.2 BY END USE, 2025-2035 (USD Billion)
      3. 7.12.3 BY TYPE OF VIRAL VECTOR, 2025-2035 (USD Billion)
      4. 7.12.4 BY SCALE OF PRODUCTION, 2025-2035 (USD Billion)
      5. 7.12.5 BY TECHNOLOGY USED, 2025-2035 (USD Billion)
    12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
      1. 7.13.1 BY APPLICATION, 2025-2035 (USD Billion)
      2. 7.13.2 BY END USE, 2025-2035 (USD Billion)
      3. 7.13.3 BY TYPE OF VIRAL VECTOR, 2025-2035 (USD Billion)
      4. 7.13.4 BY SCALE OF PRODUCTION, 2025-2035 (USD Billion)
      5. 7.13.5 BY TECHNOLOGY USED, 2025-2035 (USD Billion)
    13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
      1. 7.14.1 BY APPLICATION, 2025-2035 (USD Billion)
      2. 7.14.2 BY END USE, 2025-2035 (USD Billion)
      3. 7.14.3 BY TYPE OF VIRAL VECTOR, 2025-2035 (USD Billion)
      4. 7.14.4 BY SCALE OF PRODUCTION, 2025-2035 (USD Billion)
      5. 7.14.5 BY TECHNOLOGY USED, 2025-2035 (USD Billion)
    14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
      1. 7.15.1 BY APPLICATION, 2025-2035 (USD Billion)
      2. 7.15.2 BY END USE, 2025-2035 (USD Billion)
      3. 7.15.3 BY TYPE OF VIRAL VECTOR, 2025-2035 (USD Billion)
      4. 7.15.4 BY SCALE OF PRODUCTION, 2025-2035 (USD Billion)
      5. 7.15.5 BY TECHNOLOGY USED, 2025-2035 (USD Billion)
    15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
      1. 7.16.1 BY APPLICATION, 2025-2035 (USD Billion)
      2. 7.16.2 BY END USE, 2025-2035 (USD Billion)
      3. 7.16.3 BY TYPE OF VIRAL VECTOR, 2025-2035 (USD Billion)
      4. 7.16.4 BY SCALE OF PRODUCTION, 2025-2035 (USD Billion)
      5. 7.16.5 BY TECHNOLOGY USED, 2025-2035 (USD Billion)
    16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
      1. 7.17.1 BY APPLICATION, 2025-2035 (USD Billion)
      2. 7.17.2 BY END USE, 2025-2035 (USD Billion)
      3. 7.17.3 BY TYPE OF VIRAL VECTOR, 2025-2035 (USD Billion)
      4. 7.17.4 BY SCALE OF PRODUCTION, 2025-2035 (USD Billion)
      5. 7.17.5 BY TECHNOLOGY USED, 2025-2035 (USD Billion)
    17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
      1. 7.18.1 BY APPLICATION, 2025-2035 (USD Billion)
      2. 7.18.2 BY END USE, 2025-2035 (USD Billion)
      3. 7.18.3 BY TYPE OF VIRAL VECTOR, 2025-2035 (USD Billion)
      4. 7.18.4 BY SCALE OF PRODUCTION, 2025-2035 (USD Billion)
      5. 7.18.5 BY TECHNOLOGY USED, 2025-2035 (USD Billion)
    18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
      1. 7.19.1 BY APPLICATION, 2025-2035 (USD Billion)
      2. 7.19.2 BY END USE, 2025-2035 (USD Billion)
      3. 7.19.3 BY TYPE OF VIRAL VECTOR, 2025-2035 (USD Billion)
      4. 7.19.4 BY SCALE OF PRODUCTION, 2025-2035 (USD Billion)
      5. 7.19.5 BY TECHNOLOGY USED, 2025-2035 (USD Billion)
    19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
      1. 7.20.1 BY APPLICATION, 2025-2035 (USD Billion)
      2. 7.20.2 BY END USE, 2025-2035 (USD Billion)
      3. 7.20.3 BY TYPE OF VIRAL VECTOR, 2025-2035 (USD Billion)
      4. 7.20.4 BY SCALE OF PRODUCTION, 2025-2035 (USD Billion)
      5. 7.20.5 BY TECHNOLOGY USED, 2025-2035 (USD Billion)
    20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
      1. 7.21.1 BY APPLICATION, 2025-2035 (USD Billion)
      2. 7.21.2 BY END USE, 2025-2035 (USD Billion)
      3. 7.21.3 BY TYPE OF VIRAL VECTOR, 2025-2035 (USD Billion)
      4. 7.21.4 BY SCALE OF PRODUCTION, 2025-2035 (USD Billion)
      5. 7.21.5 BY TECHNOLOGY USED, 2025-2035 (USD Billion)
    21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
      1. 7.22.1 BY APPLICATION, 2025-2035 (USD Billion)
      2. 7.22.2 BY END USE, 2025-2035 (USD Billion)
      3. 7.22.3 BY TYPE OF VIRAL VECTOR, 2025-2035 (USD Billion)
      4. 7.22.4 BY SCALE OF PRODUCTION, 2025-2035 (USD Billion)
      5. 7.22.5 BY TECHNOLOGY USED, 2025-2035 (USD Billion)
    22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
      1. 7.23.1 BY APPLICATION, 2025-2035 (USD Billion)
      2. 7.23.2 BY END USE, 2025-2035 (USD Billion)
      3. 7.23.3 BY TYPE OF VIRAL VECTOR, 2025-2035 (USD Billion)
      4. 7.23.4 BY SCALE OF PRODUCTION, 2025-2035 (USD Billion)
      5. 7.23.5 BY TECHNOLOGY USED, 2025-2035 (USD Billion)
    23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
      1. 7.24.1 BY APPLICATION, 2025-2035 (USD Billion)
      2. 7.24.2 BY END USE, 2025-2035 (USD Billion)
      3. 7.24.3 BY TYPE OF VIRAL VECTOR, 2025-2035 (USD Billion)
      4. 7.24.4 BY SCALE OF PRODUCTION, 2025-2035 (USD Billion)
      5. 7.24.5 BY TECHNOLOGY USED, 2025-2035 (USD Billion)
    24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
      1. 7.25.1 BY APPLICATION, 2025-2035 (USD Billion)
      2. 7.25.2 BY END USE, 2025-2035 (USD Billion)
      3. 7.25.3 BY TYPE OF VIRAL VECTOR, 2025-2035 (USD Billion)
      4. 7.25.4 BY SCALE OF PRODUCTION, 2025-2035 (USD Billion)
      5. 7.25.5 BY TECHNOLOGY USED, 2025-2035 (USD Billion)
    25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
      1. 7.26.1 BY APPLICATION, 2025-2035 (USD Billion)
      2. 7.26.2 BY END USE, 2025-2035 (USD Billion)
      3. 7.26.3 BY TYPE OF VIRAL VECTOR, 2025-2035 (USD Billion)
      4. 7.26.4 BY SCALE OF PRODUCTION, 2025-2035 (USD Billion)
      5. 7.26.5 BY TECHNOLOGY USED, 2025-2035 (USD Billion)
    26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
      1. 7.27.1 BY APPLICATION, 2025-2035 (USD Billion)
      2. 7.27.2 BY END USE, 2025-2035 (USD Billion)
      3. 7.27.3 BY TYPE OF VIRAL VECTOR, 2025-2035 (USD Billion)
      4. 7.27.4 BY SCALE OF PRODUCTION, 2025-2035 (USD Billion)
      5. 7.27.5 BY TECHNOLOGY USED, 2025-2035 (USD Billion)
    27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
      1. 7.28.1 BY APPLICATION, 2025-2035 (USD Billion)
      2. 7.28.2 BY END USE, 2025-2035 (USD Billion)
      3. 7.28.3 BY TYPE OF VIRAL VECTOR, 2025-2035 (USD Billion)
      4. 7.28.4 BY SCALE OF PRODUCTION, 2025-2035 (USD Billion)
      5. 7.28.5 BY TECHNOLOGY USED, 2025-2035 (USD Billion)
    28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
      1. 7.29.1 BY APPLICATION, 2025-2035 (USD Billion)
      2. 7.29.2 BY END USE, 2025-2035 (USD Billion)
      3. 7.29.3 BY TYPE OF VIRAL VECTOR, 2025-2035 (USD Billion)
      4. 7.29.4 BY SCALE OF PRODUCTION, 2025-2035 (USD Billion)
      5. 7.29.5 BY TECHNOLOGY USED, 2025-2035 (USD Billion)
    29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
      1. 7.30.1 BY APPLICATION, 2025-2035 (USD Billion)
      2. 7.30.2 BY END USE, 2025-2035 (USD Billion)
      3. 7.30.3 BY TYPE OF VIRAL VECTOR, 2025-2035 (USD Billion)
      4. 7.30.4 BY SCALE OF PRODUCTION, 2025-2035 (USD Billion)
      5. 7.30.5 BY TECHNOLOGY USED, 2025-2035 (USD Billion)
    30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.31.1
    1. 7.32 ACQUISITION/PARTNERSHIP
  10. 7.32.1

Viral Vectors and Plasmid DNA Manufacturing Market Segmentation

Viral Vectors and Plasmid DNA Manufacturing Market By Application (USD Billion, 2025-2035)

  • Gene Therapy
  • Vaccines
  • Oncology
  • Infectious Diseases
  • Genetic Disorders

Viral Vectors and Plasmid DNA Manufacturing Market By End Use (USD Billion, 2025-2035)

  • Viral Vectors and Plasmid DNA Manufacturing Market Companies
  • Biotechnology Firms
  • Research Institutions
  • Academic Organizations

Viral Vectors and Plasmid DNA Manufacturing Market By Type of Viral Vector (USD Billion, 2025-2035)

  • Adenoviral Vectors
  • Lentiviral Vectors
  • Adeno-Associated Viral Vectors
  • Retroviral Vectors

Viral Vectors and Plasmid DNA Manufacturing Market By Scale of Production (USD Billion, 2025-2035)

  • Small Scale
  • Medium Scale
  • Large Scale

Viral Vectors and Plasmid DNA Manufacturing Market By Technology Used (USD Billion, 2025-2035)

  • Transfection
  • Electroporation
  • Viral Packaging
  • Microinjection

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.